Bank of New York Mellon »

Alnylam Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2023-12-31 $160M 837k 191.41
2023-09-30 $148M 837k 177.10
2023-06-30 $147M 776k 189.94
2023-03-31 $111M 554k 200.32
2022-12-31 $137M 574k 237.65
2022-09-30 $0 567k 0.00
2022-06-30 $99M 675k 145.88
2022-03-31 $104M 639k 163.29
2021-12-31 $0 602k 0.00
2021-09-30 $0 453k 0.00
2021-06-30 $75M 442k 169.52
2021-03-31 $60M 422k 141.19
2020-12-31 $58M 443k 129.97
2020-09-30 $63M 435k 145.60
2020-06-30 $70M 435k 160.00
2020-03-31 $48M 443k 108.85
2019-12-31 $51M 442k 115.17
2019-09-30 $36M 451k 80.42
2019-06-30 $29M 401k 72.56
2019-03-31 $37M 390k 93.45
2018-12-31 $36M 496k 72.91
2018-09-30 $45M 512k 87.52
2018-06-30 $50M 512k 98.49
2018-03-31 $47M 398k 119.10
2017-12-31 $50M 395k 127.05
2017-06-30 $27M 334k 79.76
2017-03-31 $16M 306k 51.25
2016-12-31 $11M 303k 37.44
2016-09-30 $22M 327k 67.78
2016-06-30 $19M 349k 55.49